<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03448640</url>
  </required_header>
  <id_info>
    <org_study_id>BulentEU</org_study_id>
    <nct_id>NCT03448640</nct_id>
  </id_info>
  <brief_title>Efficacy of Mydriatic Drops in Premature Infants</brief_title>
  <official_title>Efficiency and Safety of Phenylephrine and Tropicamide Used in Premature Retinopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bulent Ecevit University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bulent Ecevit University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Because of the neonatologists reported that some infants had suffered from vomiting,
      bradycardia, hypotonia, and aspiration risk about 30-60 minutes after the fundus examination
      in the intensive care unit. The investigators observed the pupil dilation effects and side
      effects of tipple instillation of phenylephrine 2.5% plus tropicamide 0.5% ophthalmic drop
      combination which the investigators routinely used in ROP examination.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purpose: To determine effect and vital change after topical application of phenylephrine 2.5%
      and tropicamide 0.5% three times for retinopathy of prematurity (ROP) examination in preterm
      infants.

      Methods: Pupillary diameter, blood pressure, pulse rate, and oxygen saturation were monitored
      before, and after up to 24 hours 60 ROP screening examinations.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 15, 2016</start_date>
  <completion_date type="Actual">December 15, 2017</completion_date>
  <primary_completion_date type="Actual">October 15, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The mean pupillary diameter</measure>
    <time_frame>an average of 1 year</time_frame>
    <description>will be measured with a ruler after 60 minutes instillation of mydriatic</description>
  </primary_outcome>
  <enrollment type="Actual">60</enrollment>
  <condition>Retinopathy of Prematurity</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Drug used in the examination of premature infants.</intervention_name>
    <description>to investigate side effects of eye drops used</description>
    <other_name>Tropicamide and mydfline used</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        tertiary health center in the west Black Sea region
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infants who were first ROP examinations

          -  infants born before 32 weeks.

        Exclusion Criteria:

          -  Developmental ocular and/or systemic anomalies.

          -  Drug use that can affect vital values

          -  Unstable general condition

          -  Food intolerance

          -  Recurrent vomiting.
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>neonatal</gender_description>
    <minimum_age>32 Weeks</minimum_age>
    <maximum_age>34 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Spencer R. Long-term visual outcomes in extremely low-birth-weight children (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2006;104:493-516.</citation>
    <PMID>17471358</PMID>
  </reference>
  <reference>
    <citation>Sindel BD, Baker MD, Maisels MJ, Weinstein J. A comparison of the pupillary and cardiovascular effects of various mydriatic agents in preterm infants. J Pediatr Ophthalmol Strabismus. 1986 Nov-Dec;23(6):273-6.</citation>
    <PMID>3454368</PMID>
  </reference>
  <reference>
    <citation>Clarke WN, Hodges E, Noel LP, Roberts D, Coneys M. The oculocardiac reflex during ophthalmoscopy in premature infants. Am J Ophthalmol. 1985 Jun 15;99(6):649-51.</citation>
    <PMID>4014388</PMID>
  </reference>
  <reference>
    <citation>Lim DL, Batilando M, Rajadurai VS. Transient paralytic ileus following the use of cyclopentolate-phenylephrine eye drops during screening for retinopathy of prematurity. J Paediatr Child Health. 2003 May-Jun;39(4):318-20.</citation>
    <PMID>12755944</PMID>
  </reference>
  <reference>
    <citation>Bonthala S, Sparks JW, Musgrove KH, Berseth CL. Mydriatics slow gastric emptying in preterm infants. J Pediatr. 2000 Sep;137(3):327-30.</citation>
    <PMID>10969255</PMID>
  </reference>
  <reference>
    <citation>Chien DS, Homsy JJ, Gluchowski C, Tang-Liu DD. Corneal and conjunctival/scleral penetration of p-aminoclonidine, AGN 190342, and clonidine in rabbit eyes. Curr Eye Res. 1990 Nov;9(11):1051-9.</citation>
    <PMID>1982760</PMID>
  </reference>
  <reference>
    <citation>Thanathanee O, Ratanapakorn T, Morley MG, Yospaiboon Y. Lower conjunctival fornix packing for mydriasis in premature infants: a randomized trial. Clin Ophthalmol. 2012;6:253-6. doi: 10.2147/OPTH.S28714. Epub 2012 Feb 15.</citation>
    <PMID>22368443</PMID>
  </reference>
  <reference>
    <citation>Cohen AM, Cook N, Harris MC, Ying GS, Binenbaum G. The pain response to mydriatic eyedrops in preterm infants. J Perinatol. 2013 Jun;33(6):462-5. doi: 10.1038/jp.2012.149. Epub 2012 Dec 13.</citation>
    <PMID>23238569</PMID>
  </reference>
  <reference>
    <citation>Ballabh P. Intraventricular hemorrhage in premature infants: mechanism of disease. Pediatr Res. 2010 Jan;67(1):1-8. doi: 10.1203/PDR.0b013e3181c1b176. Review.</citation>
    <PMID>19816235</PMID>
  </reference>
  <reference>
    <citation>Wilkinson AR, Haines L, Head K, Fielder AR. UK retinopathy of prematurity guideline. Early Hum Dev. 2008 Feb;84(2):71-4. doi: 10.1016/j.earlhumdev.2007.12.004.</citation>
    <PMID>18280404</PMID>
  </reference>
  <results_reference>
    <citation>Laws DE, Morton C, Weindling M, Clark D. Systemic effects of screening for retinopathy of prematurity. Br J Ophthalmol. 1996 May;80(5):425-8.</citation>
    <PMID>8695564</PMID>
  </results_reference>
  <results_reference>
    <citation>Lees BJ, Cabal LA. Increased blood pressure following pupillary dilation with 2.5% phenylephrine hydrochloride in preterm infants. Pediatrics. 1981 Aug;68(2):231-4.</citation>
    <PMID>7267230</PMID>
  </results_reference>
  <results_reference>
    <citation>Isenberg S, Everett S, Parelhoff E. A comparison of mydriatic eyedrops in low-weight infants. Ophthalmology. 1984 Mar;91(3):278-9.</citation>
    <PMID>6546977</PMID>
  </results_reference>
  <results_reference>
    <citation>Alpay A, Ermis B, Ugurbas SC, Battal F, Sagdik HM. The local vasoconstriction of infant's skin following instillation of mydriatic eye drops. Eur J Clin Pharmacol. 2010 Nov;66(11):1161-4. doi: 10.1007/s00228-010-0890-6. Epub 2010 Sep 11.</citation>
    <PMID>20835704</PMID>
  </results_reference>
  <results_reference>
    <citation>Khoo BK, Koh A, Cheong P, Ho NK. Combination cyclopentolate and phenylephrine for mydriasis in premature infants with heavily pigmented irides. J Pediatr Ophthalmol Strabismus. 2000 Jan-Feb;37(1):15-20.</citation>
    <PMID>10714690</PMID>
  </results_reference>
  <results_reference>
    <citation>Lux AL, Degoumois A, Barjol A, Mouriaux F, Denion E. Combination of 5% phenylephrine and 0.5% tropicamide eyedrops for pupil dilation in neonates is twice as effective as 0.5% tropicamide eyedrops alone. Acta Ophthalmol. 2017 Mar;95(2):165-169. doi: 10.1111/aos.13175. Epub 2016 Aug 13.</citation>
    <PMID>27519933</PMID>
  </results_reference>
  <results_reference>
    <citation>Oğüt MS, Bozkurt N, Ozek E, Birgen H, Kazokoğlú H, Oğüt M. Effects and side effects of mydriatic eyedrops in neonates. Eur J Ophthalmol. 1996 Apr-Jun;6(2):192-6.</citation>
    <PMID>8823596</PMID>
  </results_reference>
  <results_reference>
    <citation>Mitchell AJ, Green A, Jeffs DA, Roberson PK. Physiologic effects of retinopathy of prematurity screening examinations. Adv Neonatal Care. 2011 Aug;11(4):291-7. doi: 10.1097/ANC.0b013e318225a332.</citation>
    <PMID>22123352</PMID>
  </results_reference>
  <results_reference>
    <citation>Patel AJ, Simon JW, Hodgetts DJ. Cycloplegic and mydriatic agents for routine ophthalmologic examination: a survey of pediatric ophthalmologists. J AAPOS. 2004 Jun;8(3):274-7.</citation>
    <PMID>15226730</PMID>
  </results_reference>
  <results_reference>
    <citation>Rush R, Rush S, Nicolau J, Chapman K, Naqvi M. Systemic manifestations in response to mydriasis and physical examination during screening for retinopathy of prematurity. Retina. 2004 Apr;24(2):242-5.</citation>
    <PMID>15097885</PMID>
  </results_reference>
  <results_reference>
    <citation>Neffendorf JE, Mota PM, Xue K, Hildebrand GD. Efficacy and safety of phenylephrine 2.5% with cyclopentolate 0.5% for retinopathy of prematurity screening in 1246 eye examinations. Eur J Ophthalmol. 2015 May-Jun;25(3):249-53. doi: 10.5301/ejo.5000540. Epub 2014 Nov 14.</citation>
    <PMID>25449644</PMID>
  </results_reference>
  <results_reference>
    <citation>Mitchell A, Hall RW, Erickson SW, Yates C, Hendrickson H. Systemic Absorption of Cyclopentolate and Adverse Events After Retinopathy of Prematurity Exams. Curr Eye Res. 2016 Dec;41(12):1601-1607. Epub 2016 May 9.</citation>
    <PMID>27159349</PMID>
  </results_reference>
  <results_reference>
    <citation>Anand KJ. Clinical importance of pain and stress in preterm neonates. Biol Neonate. 1998;73(1):1-9. Review.</citation>
    <PMID>9458936</PMID>
  </results_reference>
  <results_reference>
    <citation>Belda S, Pallás CR, De la Cruz J, Tejada P. Screening for retinopathy of prematurity: is it painful? Biol Neonate. 2004;86(3):195-200. Epub 2004 Jul 5.</citation>
    <PMID>15240989</PMID>
  </results_reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2018</study_first_submitted>
  <study_first_submitted_qc>February 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 28, 2018</study_first_posted>
  <last_update_submitted>February 27, 2018</last_update_submitted>
  <last_update_submitted_qc>February 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bulent Ecevit University</investigator_affiliation>
    <investigator_full_name>Atilla Alpay</investigator_full_name>
    <investigator_title>Asociate Pofessor Atilla Alpay</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Diseases</mesh_term>
    <mesh_term>Retinopathy of Prematurity</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tropicamide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

